- Report
- November 2025
- 185 Pages
Global
From €3116EUR$3,545USD£2,721GBP
€3462EUR$3,939USD£3,023GBP
- Report
- October 2025
- 197 Pages
Global
From €3116EUR$3,545USD£2,721GBP
€3462EUR$3,939USD£3,023GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2109EUR$2,400USD£1,842GBP
€2637EUR$3,000USD£2,302GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €1758EUR$2,000USD£1,535GBP
€2197EUR$2,500USD£1,919GBP
- Report
- May 2025
- 196 Pages
Global
From €4175EUR$4,750USD£3,645GBP
- Report
- October 2025
- 250 Pages
Global
From €3946EUR$4,490USD£3,446GBP
- Report
- October 2025
- 250 Pages
Global
From €3946EUR$4,490USD£3,446GBP
- Report
- September 2025
- 250 Pages
Global
From €3946EUR$4,490USD£3,446GBP
- Report
- December 2025
- 177 Pages
Global
From €5142EUR$5,850USD£4,489GBP
- Report
- December 2025
- 194 Pages
Global
From €5142EUR$5,850USD£4,489GBP
- Report
- November 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,453GBP
- Report
- April 2025
- 186 Pages
Global
From €3955EUR$4,500USD£3,453GBP
- Report
- August 2025
- 136 Pages
Global
From €2240EUR$2,549USD£1,956GBP
€2636EUR$2,999USD£2,301GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,266USD£3,163GBP
- Report
- October 2025
- 160 Pages
Global
From €2951EUR$3,358USD£2,577GBP
€3472EUR$3,950USD£3,031GBP
- Report
- October 2025
- 100 Pages
United States
From €5230EUR$5,950USD£4,566GBP
- Report
- July 2025
- 82 Pages
United States
From €3076EUR$3,500USD£2,686GBP
- Report
- May 2025
- 120 Pages
Global
From €5230EUR$5,950USD£4,566GBP
- Report
- August 2025
- 183 Pages
Global
From €3116EUR$3,545USD£2,721GBP
€3462EUR$3,939USD£3,023GBP
- Report
- August 2025
- 184 Pages
Global
From €3116EUR$3,545USD£2,721GBP
€3462EUR$3,939USD£3,023GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more